Daihong Guo
Overview
Explore the profile of Daihong Guo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wen X, Cai L, Gao A, Fu A, Guo D, Zhu M
Int J Clin Pharm
. 2025 Jan;
PMID: 39888490
Background: Drug-induced hypofibrinogenemia has received increasing scrutiny; however, the specific drugs involved remain poorly characterized. Hypofibrinogenemia can have significant clinical implications, including increased bleeding risks. Aim: This study aimed to...
2.
Cai L, Wen X, Qiu Z, Fu A, Guo D, Zhu M
BMC Pharmacol Toxicol
. 2025 Jan;
26(1):5.
PMID: 39789607
Objective: The occurrence of hypofibrinogenemia after tocilizumab treatment has attracted increasing attention, which may cause bleeding and even life-threatening. This study aims to explore the risk factors for tocilizumab-induced hypofibrinogenemia...
3.
Li P, Zhu M, Gao A, Guo H, Fu A, Zhao A, et al.
J Clin Pharmacol
. 2024 Aug;
64(11):1351-1360.
PMID: 39092985
This study aimed to analyze the incidence, clinical characteristics, and risk factors of moxifloxacin-related arrhythmias and electrocardiographic alterations in hospitalized patients using real-world data. Concurrently, a nomogram was established and...
4.
Fu A, Ge F, Wang Y, Guo H, Zhu M, Li S, et al.
BMC Pharmacol Toxicol
. 2024 Jul;
25(1):41.
PMID: 38997770
Background And Aim: The use of cefoperazone/sulbactam (CPZ/SAM) could commonly cause vitamin K-dependent coagulation disorders and even hemorrhage sometimes. However, there is a lack of prediction tools estimating the risk...
5.
Zhao A, Guo D, Zhu M, Gao A, Li P, Fu A
Eur J Clin Pharmacol
. 2024 Mar;
80(6):911-918.
PMID: 38441574
Objective: To analyze the clinical characteristics, incidence, and distribution of drug-associated muscle adverse reactions (DAMAR) in real-world inpatients, to provide valuable references for clinical medication use. Methods: We conducted an...
6.
Li P, Zhu M, Gao A, Guo H, Fu A, Zhao A, et al.
Int J Clin Pharm
. 2024 Feb;
46(3):684-693.
PMID: 38416350
Background: Automatic monitoring and assessment are increasingly employed in drug safety evaluations using hospital information system data. The increasing concern about granisetron-related arrhythmias requires real-world studies to improve our understanding...
7.
Guo H, Li P, Guo D, Gao A, Zhao P, Fu A, et al.
Eur J Clin Pharmacol
. 2023 Apr;
79(6):759-765.
PMID: 37039873
Objective: The purpose of this study was to analyze the occurrence characteristics, clinical manifestations, medication distribution, and incidence of drug-induced arrhythmias in a real-world inpatient population. Methods: According to the...
8.
Li X, Ma Q, Yin J, Zheng Y, Chen R, Chen Y, et al.
Front Pharmacol
. 2022 Apr;
13:845689.
PMID: 35418863
For anaphylaxis, a life-threatening allergic reaction, the incidence rate was presented to have increased from the beginning of the 21st century. Underdiagnosis and undertreatment of anaphylaxis are public health concerns....
9.
Zhu Y, Guo D, Kong X, Liu S, Yu C
Pharmacology
. 2021 Oct;
107(1-2):69-80.
PMID: 34673655
Introduction: This study was conducted to develop and validate a nomogram for predicting the risk of neutropenia or febrile neutropenia (FN) in tumor patients in the first cycle of etoposide-based...
10.
Yu C, Guo D, Yao C, Zhu Y, Liu S, Kong X
Front Pharmacol
. 2021 Jul;
12:657853.
PMID: 34194322
Drug-induced acute kidney injury (D-AKI) is associated with increased mortality and longer hospital stays. This study aims to establish a nomogram to predict the occurrence of D-AKI in hospitalized patients...